Advanced non-small cell lung cancer (NSCLC) with EGFR mutations

Active Ingredient: Aumolertinib

Indication for Aumolertinib

Population group: only adults (18 years old or older)
Therapeutic intent: Curative procedure

Aumolertinib as monotherapy is indicated for the first-line treatment of adult patients with advanced non-small cell lung cancer (NSCLC) whose tumours have EGFR exon 19 deletions or exon 21 (L858R) substitution mutations.

For this indication, competent medicine agencies globally authorize below treatments:

110 mg once daily

For:

Dosage regimens

Oral, 110 milligrams aumolertinib, once daily.

Detailed description

The recommended dose of aumolertinib is 110 mg once a day.

This medicinal product should be continued until disease progression or unacceptable toxicity.

Missed dose

If a dose of aumolertinib is missed, it should be taken within the same day as soon as the patient remembers. However, if the next scheduled dose is due within 12 hours, then the missed dose must be skipped. The patient should not take two doses together to make up for a missed dose.

Dose modifications for adverse reactions

Dosing interruption and/or dose reduction or permanent discontinuation may be required based on individual safety and tolerability.

If dose reduction is necessary, then the dose should be reduced from 110 mg to 55 mg taken once daily.

Dosage considerations

Aumolertinib should be taken approximately at the same time each day.

Active ingredient

Aumolertinib

Aumolertinib is an oral, third-generation tyrosine kinase inhibitor (TKI) that targets the epidermal growth factor receptor (EGFR). It selectively and irreversibly inhibits both EGFR-sensitizing mutations (such as Exon 19 deletion and L858R) and the T790M resistance mutation. It is designed to be highly selective, minimizing impact on "wild-type" (normal) EGFR to reduce side effects. It is primarily used to treat non-small cell lung cancer (NSCLC) in patients with specific genetic mutations.

Read more about Aumolertinib

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.